Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
06/09/1999 | EP0920323A1 Novel use of phospholipids of animal origin in therapy and/or dietetics |
06/09/1999 | EP0920321A1 Vitamine preparations for reducing oxygen consumption during physical efforts |
06/09/1999 | EP0920320A2 Injectable pharmaceutical composition comprising ursodesoxycholic acid or tauroursodesoxycholic acid, a strong base and tromethamol |
06/09/1999 | EP0920319A1 Antagonists of gonadotropin releasing hormone |
06/09/1999 | EP0920318A1 Aryloxy- and arylthiosubstituted pyrimidines and triazines and derivatives thereof |
06/09/1999 | EP0920317A1 Orally applicable formulation of quinolone or naphthyridone carboxylic acids |
06/09/1999 | EP0920316A1 Treatment of psychotic disorders |
06/09/1999 | EP0920315A1 Treatment of upper airway allergic responses with a combination of histamine receptor antagonists |
06/09/1999 | EP0920314A1 Non-peptide g-csf mimetics |
06/09/1999 | EP0920313A1 Methods and compositions for treating urinary incontinence using enantiomerically enriched (s,s)-glycopyrrolate |
06/09/1999 | EP0920312A1 Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents |
06/09/1999 | EP0920311A1 Parenteral paclitaxel in a stable non-toxic formulation |
06/09/1999 | EP0920310A1 Use of aminothiolester derivatives in pharmaceutics |
06/09/1999 | EP0920309A1 Conjugated linoleic acid to maintain or enhance bone mineral content |
06/09/1999 | EP0920308A1 Composition containing calcium, vitamin d and amino acids for treating osteoporosis and promoting bone fracture repair |
06/09/1999 | EP0920306A2 Chemokine receptor antagonists and methods of use therefor |
06/09/1999 | EP0920305A1 Identification of genes altered in multiple myeloma |
06/09/1999 | EP0920300A1 Vegetable oil compositions |
06/09/1999 | EP0920262A1 Nutritional formulations containing water-miscible lipid derivatives as antimicrobial agents |
06/09/1999 | EP0920253A1 Il-8 receptor antagonists |
06/09/1999 | EP0892639A4 Method of treating undesired uterine contractions using optically pure r- or rr-isomers of adrenergic beta-2 agonists |
06/09/1999 | EP0880532A4 Non-nucleotide phosphorous ester oligomers |
06/09/1999 | EP0877563A4 Food and vitamin preparations containing the natural isomer of reduced folates |
06/09/1999 | EP0828482A4 Cosmetic make-up compositions |
06/09/1999 | EP0808157B1 Medicated tissue paper product |
06/09/1999 | EP0799223B1 Piperidineacetic acid derivatives useful as fibrinogen antagonist agent |
06/09/1999 | EP0799035A4 Emulsion suitable for administering a sphingolipid and use thereof |
06/09/1999 | EP0784613B1 Colchicine derivatives and the therapeutical use thereof |
06/09/1999 | EP0775103B1 Retinoic acid x-receptor ligands |
06/09/1999 | EP0763012B1 Succinyl hydroxamic acid, n-formyl-n-hydroxy amino carboxylic acid and succinic acid amide derivatives as metalloprotease inhibitors |
06/09/1999 | EP0752981B1 Substituted cyclopentylamine derivatives and their use as calcium channel antagonists |
06/09/1999 | EP0751932B1 Vitamin-d amide derivatives |
06/09/1999 | EP0748321B1 Process for the preparation of an indazole-3-carboxamide derivative |
06/09/1999 | EP0734260B1 Paroxetine tablets and process to prepare them |
06/09/1999 | EP0730598B1 Hindered esters of rapamycin and their use as pharmaceuticals |
06/09/1999 | EP0713390B1 Gelatin capsules containing a highly concentrated acetaminophen solution |
06/09/1999 | EP0666738B1 Inhibitors of farnesyl-protein transferase |
06/09/1999 | EP0647636B1 Benzothiazole compound, process for producing the same, and use thereof |
06/09/1999 | EP0630232B1 Method of treatment for nasal and sinus dysfunction, and horseradish preparation therefor |
06/09/1999 | EP0626963B1 Vinylene-azaindole derivatives and process for their preparation |
06/09/1999 | EP0615549B1 Process for the preparation of pharmaceutically active thiazolidine or oxazolidine compounds by a yeast reductase |
06/09/1999 | EP0614456B1 1alpha,24(s)-dihydroxy vitamin d2, its formation and use |
06/09/1999 | EP0589047B1 Method of treating infectious disease, method of preventing putrefaction of cosmetic, and antibacterial/antifungal agent and cosmetic |
06/09/1999 | EP0578723B1 PROCESS FOR PURIFICATION OF HMG-CoA REDUCTASE INHIBITORS |
06/09/1999 | CN1219174A Inhibitors of protein farnesyl transferase |
06/09/1999 | CN1219173A Pyrroloazepine compounds |
06/09/1999 | CN1219172A Novel benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists |
06/09/1999 | CN1219171A Benzofuran carboxamides and their therapeutic use |
06/09/1999 | CN1219170A Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
06/09/1999 | CN1219169A Substituted benzylamines and their use for the treatment of depression |
06/09/1999 | CN1219168A Quinoline carboxamides as TNF inhibitors and as PDC-IV inhibitors |
06/09/1999 | CN1219166A Biphenylsulfonamide matrix metalloproteinase inhibitors |
06/09/1999 | CN1219165A Tricyclic compounds having activity specific for integrins, particularly alpha v beta 3 integrins, method for preparing same |
06/09/1999 | CN1219133A Administration of polypeptide growth factors following central nervous system ischemia or trauma |
06/09/1999 | CN1219132A Sustained-release prostaglandin I derivative preparation |
06/09/1999 | CN1219131A Quinoline carboxamides as TNF inhibitors and as PDC-IV inhibitors |
06/09/1999 | CN1219130A Composition comprising a nitrone compound for use in treating ocular inflammation |
06/09/1999 | CN1219129A Use of substituted azaspirane in treatment of asthma |
06/09/1999 | CN1219128A Method of increasing nitric oxide synthesis |
06/09/1999 | CN1219127A Therapeutic anti-asthma agents containing selenium compounds |
06/09/1999 | CN1219125A Intracoronary stents fixing mould containing quinazolinone derivatives |
06/09/1999 | CN1219124A Use of nitrogen-containing complexing agents for deodorization and antimicrobial treatment of skin and textile fibre materials |
06/09/1999 | CN1219104A Method of treating renomous bites and stings |
06/09/1999 | CN1219103A Antibiotic cocktail and method of use |
06/09/1999 | CN1218836A Biological synthetic technology for 1,6-fructose diphosphate |
06/09/1999 | CN1218811A Novel seco compounds from the class of tylosins |
06/09/1999 | CN1218808A Dithio-heterocyclic-pentylene acetamide derivatives |
06/09/1999 | CN1218806A Sorbic acid vitamin C ester |
06/09/1999 | CN1218802A Substituted isoquinoline-3-formamides compounds, its preparing method and its use as medicine |
06/09/1999 | CN1218801A Tri-substituted imidazoles, and process of their preparation and using the same and having their pharmic composition |
06/09/1999 | CN1218797A Process for preparing optical 2-amino-omega-oxo alkane acid derivative |
06/09/1999 | CN1218692A Novel Anti-spasmodic composition and process for manufacture thereof |
06/09/1999 | CN1218680A Liquid for curing scald and burn and its preparing method |
06/09/1999 | CN1218665A High efficiency mifepristone preparation and its preparing method and use |
06/09/1999 | CN1218664A Method for preparing butethanol of injection |
06/09/1999 | CN1218663A Use of 2'-ascorbate phosphate for stabilizing vitamin A and/or vitamin A derivative in cosmetic and modicinal preparation |
06/09/1999 | CN1218661A Cosmetics and medicine containing light stable ultraviolet filter agent |
06/09/1999 | CN1218660A Cosmetics and medicinal preparation containing lightfast ultraviolet filter agent |
06/09/1999 | CN1043576C Pyrido (1,2,3-de) quinoxaline derivatives, process for preparing the same and their use in medicine |
06/09/1999 | CN1043575C Silylated acetylcholinesterase inhibitors |
06/09/1999 | CN1043574C Heterocyclic amines having central nervous system activity |
06/08/1999 | US5910609 Compounds |
06/08/1999 | US5910593 Highly selective process for the preparation of enantiomerically pure phenylsubstituted 1,4-dihydropyridine-3,5-dicarboxylic acid derivatives |
06/08/1999 | US5910592 Substituted thiazolidinedione derivatives |
06/08/1999 | US5910586 Tricyclic aminoalkylcarboxamides; dopamine D3 receptor subtype specific ligands |
06/08/1999 | US5910513 Substituted benzyl derivatives of polyalkylene polyamines and their use in cosmetic and pharmaceutical compositions |
06/08/1999 | US5910512 Capsaicin, magnesium oxide, disodium edta and water; no harsh solvents, gentle to skin; treating rheumatoid arthritis, muscle pain |
06/08/1999 | US5910510 Administering a photoactive absorber, e.g. a porphyrin, and waiting to have it localize in ocular tissue; radiating with laser light; macular degeneration; treating neovascularization |
06/08/1999 | US5910508 Novel compounds useful in modulating cellular hormone receptors; treating skin disorders such as acne, psoriasis |
06/08/1999 | US5910506 Imidazole derivatives as anti-HIV agents |
06/08/1999 | US5910505 Leukotriene antagonists for use in the treatment or inhibition of oral squamous cell carcinoma |
06/08/1999 | US5910504 Hetero-aromatic ring substituted phenyloxazolidinone antimicrobials |
06/08/1999 | US5910502 Use of levobupivacaine in paediatric surgery |
06/08/1999 | US5910501 Use of certain esters of hexahydro-8-hydroxy-2,6-methano-2H-quinolozin-3(4H)-one and related compounds for treating cognitive disorders |
06/08/1999 | US5910499 Leukotriene production inhibiting action and antihistaminic action; oral administration |
06/08/1999 | US5910497 Treating acne vulgaris |
06/08/1999 | US5910495 Use of 1,5-benzo b!1,4-diazepines to control gastric emptying |
06/08/1999 | US5910494 Hypolipidemic 1,4-benzothiazepine-1,1-dioxides |
06/08/1999 | US5910491 Highly lipophilic camptothecin derivatives |
06/08/1999 | US5910490 Inhibition of membrane receptors for elastin which are involved in degradation of fibrous stroma of the connective tissue |